Casserly Brian, O'Mahony Elizabeth, Timm Edward G, Haqqie Syed, Eisele George, Urizar Rodrigo
Department of Internal Medicine, Albany Medical Center Hospital, Albany, NY, USA.
Am J Kidney Dis. 2004 Dec;44(6):e98-101. doi: 10.1053/j.ajkd.2004.08.036.
Propofol infusion syndrome has been increasingly recognized as a syndrome of unexplained myocardial failure, metabolic acidosis, and rhabdomyolysis with renal failure. It has been described only with acute neurologic injury or acute inflammatory diseases complicated by severe infections or sepsis. It appears to develop in the context of high-dose, prolonged propofol (100 microg/kg/min) treatment in combination with catecholamines and/or steroids. This was first noted in children but is increasingly recognized in adults. This is a case report of 2 patients (a 42-year-old man and a 17-year-old girl) who had acute renal failure associated with use of propofol in the appropriate clinical setting. It examines the pathophysiology and the possible mechanisms of this condition and illustrates the need to consider it as the cause of rhabdomyolysis and acute renal failure in critically ill patients.
丙泊酚输注综合征越来越被认为是一种原因不明的心肌衰竭、代谢性酸中毒以及伴有肾衰竭的横纹肌溶解症候群。它仅在急性神经损伤或并发严重感染或脓毒症的急性炎症性疾病中被描述过。它似乎在大剂量、长时间(100微克/千克/分钟)使用丙泊酚并联合儿茶酚胺和/或类固醇的情况下发生。这一情况最初在儿童中被注意到,但在成人中也越来越被认识到。本文报告了2例患者(一名42岁男性和一名17岁女孩),他们在适当的临床环境中使用丙泊酚后出现了急性肾衰竭。本文探讨了这种情况的病理生理学及可能机制,并说明了在危重症患者中需要将其视为横纹肌溶解症和急性肾衰竭病因的必要性。